Loading…
“Start private, end private”—a principle that could help protect the NHS from subsidising private care
[...]urgent action is needed to strengthen existing regulations for POCTs.8 Currently, manufacturers need only demonstrate a POCT is “equivalent” to a standard laboratory test. [...]before any test or procedure, private providers should be mandated to give patients clear information regarding the be...
Saved in:
Published in: | BMJ (Online) 2024-05, Vol.385, p.q1155-q1155 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]urgent action is needed to strengthen existing regulations for POCTs.8 Currently, manufacturers need only demonstrate a POCT is “equivalent” to a standard laboratory test. [...]before any test or procedure, private providers should be mandated to give patients clear information regarding the benefits and harms of care. [...]the private sector (insurers, hospitals, clinics, private screening companies, POCT manufacturers) should be responsible for covering these costs in full, which should be quantified and included upfront within the price of the test or procedure at purchase by the patient and passed to the NHS as appropriate. |
---|---|
ISSN: | 1756-1833 1756-1833 |
DOI: | 10.1136/bmj.q1155 |